Molex, LLC (Phillips Medsize)

Medical device contract manufacturer · Costa Mesa, California, United States

Molex, LLC (Phillips Medsize) is a medical device contract manufacturer with a registered site in Costa Mesa, California, United States. The US FDA lists 1 medical device site registered to the company, with devices in cardiovascular, radiology and ophthalmic.

Profile compiled from public records. Is this your company? Request a correction or update

Molex, LLC (Phillips Medsize) at a glance

Typemedical device contract manufacturer
Registered siteCosta Mesa, California, United States
FDA-registered sites1

What does Molex, LLC (Phillips Medsize) do?

Medical specialties of its FDA-listed devices

CardiovascularRadiologyOphthalmic

Device types listed with the FDA

Catheter, electrode recording, or probe, electrode recordingCable, transducer and electrode, patient, (including connector)Amplifier and signal conditioner, transducer signalComputer, diagnostic, programmableVentricular (assist) bypassTransducer, ultrasonic, diagnosticSystem, imaging, pulsed echo, ultrasonicSystem, imaging, pulsed doppler, ultrasonic

Where is Molex, LLC (Phillips Medsize) located?

Registered site: Costa Mesa, California, United States

  • Costa Mesa, CaliforniaPhillips-Medisize Costa Mesa LLC · FDA device site

Frequently asked questions about Molex, LLC (Phillips Medsize)

Where is Molex, LLC (Phillips Medsize) based?

Molex, LLC (Phillips Medsize) is based in Costa Mesa, California, United States.

What does Molex, LLC (Phillips Medsize) do?

Molex, LLC (Phillips Medsize) is a medical device contract manufacturer. Its FDA-listed medical devices fall under cardiovascular, radiology and ophthalmic.

Similar companies

Work with CROs and CDMOs like Molex, LLC (Phillips Medsize)

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

List your services on BioBridgeX

Last updated 2026-09-23. Data licences

Molex, LLC (Phillips Medsize): Headquarters, Locations & Company Profile (2026) | BioBridgeX